Clik here to view.
Hospira lowers 2013 forecast after FDA bans more infusion pump imports
Infusion pump maker Hospira (NYSE:HSP) restated its 2013 financial guidance after the FDA banned imports of certain of Hospira’s infusion pumps. Hospira received word yesterday that the FDA had...
View ArticleClik here to view.
Sirona gains despite flat profits
Sirona Dental Systems (NSDQ:SIRO) reported flat profits for its fiscal 1st quarter, but that didn’t faze investors, who sent share prices up nearly 4% this week. The Long Island City, N.Y.-based...
View ArticleClik here to view.
Medical aesthetics: Cynosure, Syneron gain on swings to black
IF their 4th-quarter and full-year results are anything to go by, the slumping medical aesthetics market is on the rebound, as Syneron Medical Ltd. (NSDQ:ELOS) and Cynosure (NSDQ:CYNO) report returns...
View ArticleClik here to view.
ArthroCare shares flat on DoJ overhang despite swings to Q4, 2012 black
Investors stayed on the sidelines last week on shares of ArthroCare (NSDQ:ARTC), despite its return to black ink for both the 4th quarter and full year, as they awaited more information on pending...
View ArticleClik here to view.
Medtronic’s Q3 sales, earnings rise
Medtronic (NYSE:MDT) posted profit and sales gains during its fiscal 3rd quarter this morning, eating Wall Street analysts’ earnings expectations along the way. The Fridley, Minn.-based company, which...
View ArticleClik here to view.
Orthofix Q4 earnings boom but sales lag on challenges overseas
Medical device maker Orthofix (NSDQ:OFIX) posted huge growth for its bottom line in both the 4th quarter and full year of 2012, but reported sliding sales and projected slow growth for the year ahead....
View ArticleClik here to view.
Volcano shares dive on lowered guidance
Shares of Volcano (NSDQ:VOLC) were down nearly 10% on Wall Street in late-day trading Friday, after the medical device company revised its sales and earnings guidance downwards, a day after a tough...
View ArticleClik here to view.
Wright Medical gains on swing to 2012 black
Shares of Wright Medical (NSDQ:WMGI) are up about 6% since the medical device company reported a return to annual profitability last week on strong 4th-quarter results. The Arlington, Tenn.-based...
View ArticleClik here to view.
Medtronic’s Irish profits rise 119% | Wall Street Beat
One of the largest employers on the Emerald Isle, Medtronic (NYSE:MDT), saw its Irish subsidiary’s pre-tax profits surge 119% during its last fiscal year, on sales growth of 43%. The Fridley,...
View ArticleClik here to view.
NuVasive gains on narrower Q4 losses, revenue beat
Shares of NuVasive Inc. (NSDQ:NUVA) closed up nearly 7% yesterday after the medical device company reported narrowing its 4th-quarter losses by some 73% and beat Wall Street’s sales expectations for...
View ArticleClik here to view.
HeartWare’s Q4, 2012 sales surge
Sales of its implantable heart pump surged during the 4th quarter and 2012 for HeartWare International (NSDQ:HTWR) after the medical device company won FDA approval for its flagship left ventricular...
View ArticleClik here to view.
Philips swings to 2012 profits on strong healthcare demand
Philips (NYSE:PHG) posted 2012 profits on a strong contribution from its healthcare business, its largest segment, sending share prices for the Dutch parent company up 1.7% today on Wall Street....
View ArticleClik here to view.
Mako gets a Wall Street boost as sales soar, losses narrow in 2012
Surgical devices maker Mako Surgical (NSDQ:MAKO), maker of the Rio robotic surgery system, posted impressive boosts to its sales during the 4th quarter and full year of 2012. Mako saw increases in...
View ArticleClik here to view.
NxStage Medical surges nearly 8% after beating Wall Street
NxStage Medical (NSDQ:NXTM) shares jumped nearly 8% today after the medical device company reported Wall-Street-beating results for the 4th quarter and 2012. The Lawrence, Mass.-based medical device...
View ArticleClik here to view.
UPDATE: NxStage Medical CEO on its Wall-Street-beating Q4 results
NxStage Medical (NSDQ:NXTM) shares jumped nearly 8% today after the medical device company reported Wall-Street-beating results for the 4th quarter and 2012. The Lawrence, Mass.-based medical device...
View ArticleClik here to view.
Hansen Medical’s Q4 profits rise on patent deal, but 2012 losses still widen
Hansen Medical (NSDQ:HNSN) managed to eke out a profit during the 4th quarter on the sale and licensing of some of its patents, but still posted wider losses for 2012, sending shares down on Wall...
View ArticleClik here to view.
Diabetes: Insulet gains on strong Q4, lands FDA win
Medical device maker Insulet (NSDQ:PODD) got a boost from Wall Street last week after releasing its 4th quarter and full-year 2012 financial report. The news sent PODD shares up 5.5% in a single day...
View ArticleClik here to view.
AtriCure slips on missed Q4, 2012 results
AtriCure (NSDQ:ATRC) reported wider losses for 2012 and missed Wall Street’s expectations with its Q4 and full-year results, sending shares down on The Street last week. The West Chester, Ohio-based...
View ArticleClik here to view.
Kips Bay rises on FDA trial approval, despite losses in sales and revenue
Medical device maker Kips Bay Medical (NSDQ:KIPS) saw widening losses and sinking sales during its most recent quarter, but the company marked an important win with FDA approval to complete full...
View ArticleClik here to view.
Sanuwave slashes workforce by 65%, but pares losses by more than a third
Sanuwave Health (OTC:SNWV) laid off more than ⅓ of its workforce in its quest to pare its 2012 losses, according to a regulatory filing, shrinking from 28 employees to 10. The 64% workforce reduction...
View ArticleClik here to view.
FDA approves 1st Type 2 diabetes drug | Wall Street Beat
The FDA approved a 1st-of-its-kind treatment for Type 2 diabetes, Johnson & Johnson‘s (NYSE:JNJ) Invokana, with the federal watchdog agency citing it as a pioneer in a new class of diabetes drug....
View ArticleClik here to view.
FDA accepts Edap’s Ablatherm PMA application
Edap (NSDQ:EDAP) said the FDA accepted its pre-market approval application for its Ablatherm ultrasound prostate cancer treatment, backed by data from its Enlight investigational device exemption...
View ArticleClik here to view.
EDAP’s losses widen, sales increase in 2012
EDAP (NSDQ:EDAP) posted a slight bump in sales but a dramatic increase in losses for the fiscal year of 2012 The French device maker posted year-end losses of $9.7 million, or 55¢ per diluted share,...
View ArticleClik here to view.
Biomet swings to Q4 black, pares fiscal 2013 losses
Biomet said it posted black ink during the 4th quarter and cut its losses for fiscal 2013, reporting a 1.0 % decline in large joint reconstruction sales. The privately held medical device company,...
View ArticleClik here to view.
Sales are flat, profits plunge in the 2nd quarter for Symmetry Medical
Symmetry Medical (NYSE:SMA) saw its 2nd-quarter profits plunge more than 28% on flat sales and lowered its outlook for the balance of the year. The Warsaw, Ind.-based medical device company posted...
View Article